InvestorsHub Logo
icon url

dabullishbear

09/27/17 1:38 PM

#11869 RE: dabullishbear #11868

I just found an article that lends more credibility to the potential of Prolanta (G129R). Here is an excerpt from it that I found to be very intriguing:

"Antagonists
Various candidates have been generated by different laboratories, but none has yet entered clinical trials. One of them, namely ?1–9-G129R-hPRL, appears to be promising, as it is the only one displaying both PRL receptor specificity and pure antagonism [6]."

Here is the link to the article:

http://www.sciencedirect.com/topics/neuroscience/type-i-cytokine-receptor

Remember, Prolanta is also the only known cancer treatment out there that works by the method of autophagy.